Recent YSCC Discoveries

Why do lung cancer drugs stop working, and why does the immune system miss tumors? Yale’s Katerina Politi is finding answers that could reshape care.

James L. Boyer, MD, Ensign Professor of Medicine (digestive diseases) and emeritus director of the Yale Liver Center, has been a leading researcher and clinician in the field of bile secretion and cholestasis. In a Q&A, Boyer discusses his early beginnings in scientific research, some of his most meaningful discoveries, and the curiosity that leads him to continue his work after nearly 70 years in the field.

Naftali Kaminski, MD, Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine (Pulmonary), has received an honorary doctorate from the School of Medicine at the University of Patras in Greece.

Throughout the academic year, faculty career development workshops, wellness webinars, and OAPD Grand Rounds are offered to help you thrive both personally and professionally as you pursue your career at YSM.

Yale School of Medicine receives $10M from the Blavatnik Family Foundation to launch a new inflammation science initiative.

In a new study, Yale researchers found aging weakens the structures that help eggs reduce their chromosome numbers accurately.

A novel study, with authors from the Department of Pediatrics and the Yale Child Study Center, on genotype-phenotype correlations in autism and the challenging analysis of comparing genetic and EEG data was recently published in the Journal of Neural Transmission.

The new drug, bavdegalutamide, activates the body’s own protein degradation system against prostate cancer.

Researchers at Yale School of Medicine have developed two approaches that improve the amount and integrity of RNA that can be recovered from precision-cut lung slices, giving researchers better tools to study living human lung tissue outside the body.